Publication:
Clinically Informative microRNAs for SARS-CoV Infection

dc.authorscopusid55878163500
dc.authorscopusid57203118181
dc.authorscopusid7006674563
dc.authorwosidErgün, Sercan/I-8798-2019
dc.contributor.authorErgun, Sercan
dc.contributor.authorSankaranarayanan, Ramamoorthy
dc.contributor.authorPetrovic, Nina
dc.contributor.authorIDPetrovic, Nina/0000-0003-2503-1228
dc.date.accessioned2025-12-11T01:08:16Z
dc.date.issued2023
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Ergun, Sercan] Ondokuz Mayis Univ, Fac Med, Dept Med Biol, Samsun, Turkiye; [Ergun, Sercan] Ondokuz Mayis Univ, Grad Inst, Dept Multidisciplinary Mol Med, Samsun, Turkiye; [Sankaranarayanan, Ramamoorthy] Madurai Kamaraj Univ, Sch Biol Sci, Dept Plant Sci, Madurai, Tamil Nadu, India; [Petrovic, Nina] Univ Belgrade, Lab Radiobiol & Mol Genet, Natl Inst Republ Serbia, VINCA Inst Nucl Sci,Dept Hlth & Environm, Mike Petrovica Alasa 12-14, Belgrade, Serbia; [Petrovic, Nina] Inst Oncol & Radiol Serbia, Dept Expt Oncol, Pasterova 14, Belgrade 11000, Serbiaen_US
dc.descriptionPetrovic, Nina/0000-0003-2503-1228en_US
dc.description.abstractCOVID-19 is a viral respiratory infection induced by the newly discovered coronavirus SARS-CoV-2. miRNA is an example of a strong and direct regulator of a gene's transcriptional activity. The interaction between miRNAs and their target molecules is responsible for homeostasis. Virus-derived and host-derived miRNAs are involved in the activity of hiding from immune system cells, inducing the inflammatory reaction through interplay with associated genes, during SARS-COV-2 infection. Interest in miRNAs has raised the comprehension of the machinery and pathophysiology of SARS-COV-2 infection. In this review, the effects and biological roles of miRNAs on SARS-CoV-2 pathogenicity and life cycle are described. The therapeutic potential of miRNAs against SARS-CoV-2 infection are also mentioned. Small regulatory nucleic acids, miRNAs, may provide diagnostic and therapeutic potential for COVID-19.en_US
dc.description.sponsorshipMinistry of Education, Science and Technological Development of the Republic of Serbia, Laboratory for Radiobiology and Molecular Genetics, Department of Health and Environment, 'VINCA' Institute of Nuclear Sciences - National Institute of the Republic of [451-03-9/2021-14/200017]; Institute for Oncology and Radiology of Serbia [451-03-9/2021-14/200043]en_US
dc.description.sponsorshipThe authors would like to thank the Ministry of Education, Science and Technological Development of the Republic of Serbia, Laboratory for Radiobiology and Molecular Genetics, Department of Health and Environment, 'VINCA' Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade (no. 451-03-9/2021-14/200017) and Institute for Oncology and Radiology of Serbia (no. Y451-03-9/2021-14/200043). Moreover, the authors would like to thank Y Keles for her support in drawing Figure & nbsp;1.en_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.doi10.2217/epi-2023-0179
dc.identifier.endpage716en_US
dc.identifier.issn1750-1911
dc.identifier.issn1750-192X
dc.identifier.issue13en_US
dc.identifier.pmid37661862
dc.identifier.scopus2-s2.0-85171309495
dc.identifier.scopusqualityQ2
dc.identifier.startpage705en_US
dc.identifier.urihttps://doi.org/10.2217/epi-2023-0179
dc.identifier.urihttps://hdl.handle.net/20.500.12712/41536
dc.identifier.volume15en_US
dc.identifier.wosWOS:001057952300001
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherFuture Medicine Ltden_US
dc.relation.ispartofEpigenomicsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectDiagnosisen_US
dc.subjectMicroRNAen_US
dc.subjectSARS-CoV-2en_US
dc.subjectTranscriptional Regulationen_US
dc.subjectViral Infectionen_US
dc.titleClinically Informative microRNAs for SARS-CoV Infectionen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files